Search results for "RADIATION"

showing 10 items of 5298 documents

In regard to tarnawski et al., IJROBP 2002;52:1271–1276

2002

Cancer ResearchRadiationOncologybusiness.industryMedicineRadiology Nuclear Medicine and imagingbusinessHumanitiesInternational Journal of Radiation Oncology*Biology*Physics
researchProduct

In Regard to Chung et al

2015

Cancer ResearchRadiationOncologybusiness.industryTerminology as Topicmedicine.medical_treatmentmedicineHumansRadiology Nuclear Medicine and imagingRadiosurgerybusinessNuclear medicineRadiosurgeryInternational Journal of Radiation Oncology*Biology*Physics
researchProduct

Pancreatic tumors show high levels of hypoxia: regarding Koong et al. IJROBP 2000;48:919–922

2001

Cancer ResearchRadiationText miningOncologybusiness.industryCancer researchMedicineRadiology Nuclear Medicine and imagingHypoxia (medical)medicine.symptombusinessInternational Journal of Radiation Oncology*Biology*Physics
researchProduct

Prostate Metabolism After the Completion of Exclusive Radiation Is More Depleted After Seeds Brachytherapy Compared to External Beam Radiation Therap…

2012

International audience; Biochemical outcome after radiation therapy requires a protracted time. PSA decreases slowly over time so that it is difficult to differentiate immediately after the completion of radiation the impact of radiation in the prostate using brachytherapy or external radiotherapy. At 3 months, the mean PSA values were similar between the 2 groups: 2.54 ng/mL (±1.59) in the EBRT group and 1.88 ng/mL (±1.14) in the PPI group (p=0.23). For Choline levels, 3-months Choline / Baseline Choline ratios were 1.13 (±0.60) after EBRT vs. 0.45 (±0.23) in the PPI group (p=0.003). Similar results were observed for Citrate levels: 3-months Citrate level / Baseline Citrate level ratios we…

Cancer ResearchRadiation[ INFO.INFO-IM ] Computer Science [cs]/Medical Imagingbusiness.industrymedicine.medical_treatmentBrachytherapyExternal beam radiation[INFO.INFO-IM] Computer Science [cs]/Medical ImagingMetabolismmedicine.disease3. Good healthRadiation therapychemistry.chemical_compoundProstate cancermedicine.anatomical_structureOncologychemistryProstatemedicine[INFO.INFO-IM]Computer Science [cs]/Medical ImagingCholineRadiology Nuclear Medicine and imagingExternal beam radiotherapyNuclear medicinebusiness
researchProduct

Radiation Therapy in Palestine: Not Only Money, But Also Real Accessibility

2017

Cancer ResearchRadiationbusiness.industrymedicine.medical_treatmentInternet privacyRadiation therapy03 medical and health sciences0302 clinical medicineOncology030220 oncology & carcinogenesismedicineRadiology Nuclear Medicine and imaging030212 general & internal medicinePalestinebusinessInternational Journal of Radiation Oncology*Biology*Physics
researchProduct

Second St. Gallen European Organisation for Research and Treatment of Cancer Gastrointestinal Cancer Conference: consensus recommendations on controv…

2016

Contains fulltext : 171468pub.pdf (Publisher’s version ) (Open Access) Primary treatment of rectal cancer was the focus of the second St. Gallen European Organisation for Research and Treatment of Cancer (EORTC) Gastrointestinal Cancer Conference. In the context of the conference, a multidisciplinary international expert panel discussed and voted on controversial issues which could not be easily answered using published evidence. Main topics included optimal pretherapeutic imaging, indication and type of neoadjuvant treatment, and the treatment strategies in advanced tumours. Here we report the key recommendations and summarise the related evidence. The treatment strategy for localised rect…

Cancer ResearchStagingColorectal cancermedicine.medical_treatmentNeoplasias Gastrointestinais030230 surgerySYNCHRONOUS LIVER METASTASESImagingCOLORECTAL-CANCER0302 clinical medicineADJUVANT CHEMOTHERAPYTumours of the digestive tract Radboud Institute for Molecular Life Sciences [Radboudumc 14]SHORT-COURSE RADIOTHERAPYRectal cancerNeoadjuvant therapyGastrointestinal NeoplasmsRectal Neoplasms/drug therapyCombination chemotherapyChemoradiotherapyCombined Modality TherapyTotal mesorectal excisionNeoadjuvant TherapyEuropeNeoplasias do Recto/quimioterapiaOncology030220 oncology & carcinogenesisMEDIAN FOLLOW-UPLife Sciences & BiomedicineDiagnostic Imagingmedicine.medical_specialtyAntineoplastic AgentsLOCAL RECURRENCERisk AssessmentCOURSE PREOPERATIVE RADIOTHERAPY03 medical and health sciencesmedicineHumansGastrointestinal cancerOncology & CarcinogenesisRadiochemotherapyNeoplasm StagingScience & TechnologyRadiotherapyRectal Neoplasmsbusiness.industryGeneral surgeryTOTAL MESORECTAL EXCISIONCancerRANDOMIZED PHASE-IIImedicine.diseaseSurgeryRadiation therapySurgerybusiness1112 Oncology And CarcinogenesisChemoradiotherapyPOSTOPERATIVE CHEMORADIOTHERAPY
researchProduct

Desferrioxamine as an appropriate chelator for 90Nb: Comparison of its complexation properties for M-Df-Octreotide (M=Nb, Fe, Ga, Zr)

2014

The niobium-90 radioisotope ((90)Nb) holds considerable promise for use in immuno-PET, due to its decay parameters (t½ = 14.6h, positron yield=53%, Eß(+)(mean) = 0.35 MeV and Eß(+)(max) = 1.5 MeV). In particular, (90)Nb appears well suited to detect in vivo the pharmacokinetics of large targeting vectors (50-150 kDa). In order to be useful for immuno-PET chelators are required to both stabilize the radionuclide in terms of coordination chemistry and to facilitate the covalent attachment to the targeting vector. Different chelators were evaluated for this purpose in terms of radiolabelling efficiency and stability of the radiolabelled Nb(V) complex and in order to determine the most suitable…

Cancer ResearchStereochemistryNiobiumMetal ions in aqueous solutionKineticsOctreotideRadiation DosageCoordination complexTransmetalationDrug StabilityMaterials TestingMoleculeRadiology Nuclear Medicine and imagingChelationChelating AgentsIonsRadioisotopeschemistry.chemical_classificationChemistryMetalsCovalent bondIsotope LabelingMolecular MedicineRadiopharmaceuticalsNuclear chemistryConjugateNuclear Medicine and Biology
researchProduct

Identification of Risk Loci for Radiotoxicity in Prostate Cancer by Comprehensive Genotyping of

2021

Simple Summary Genetic variability in transforming growth factor beta pathway (TGFB) has been reported to affect adverse events in radiotherapy. We investigated 40 germline polymorphisms in peripheral blood cells, covering the entire common genetic variability in the TGFβ1 ligand (gene TGFB1) and the TGFβ receptor-1 (TGFBR1) in 240 patients treated with primary radiotherapy for prostate cancer. Human lymphoblastoid cell lines (LCLs) were used to assess whether TGFB1 and TGFBR1 polymorphisms impact DNA repair capacity following single irradiation with 3 Gy. Upon adjustment for multiplicity testing, for one polymorphism (rs10512263 in TGFBR1, C-variant allele, n = 35), a statistically signifi…

Cancer ResearchTGFBDNA repairSNPLeu10ProArticle03 medical and health sciencesProstate cancerchemistry.chemical_compound0302 clinical medicineGenotypeMedicineGenetic variabilityAlleleGenotypingRC254-282radiotherapyTGBF1030304 developmental biology0303 health sciencesirradiationbusiness.industryNeoplasms. Tumors. Oncology. Including cancer and carcinogenstoxicitybiomarkersLCLmedicine.diseaseprostate cancerAcute toxicity3. Good healthrs10512263side effectsOncologychemistry030220 oncology & carcinogenesisCancer researchbusinessCytosineCancers
researchProduct

Fractionated External Beam Radiotherapy as a Suitable Preparative Regimen for Hepatocyte Transplantation After Partial Hepatectomy

2010

Purpose Hepatocyte transplantation is strongly considered to be a promising option to correct chronic liver failure through repopulation of the diseased organ. We already reported on extensive liver repopulation by hepatocytes transplanted into rats preconditioned with 25-Gy single dose selective external beam irradiation (IR). Herein, we tested lower radiation doses and fractionated protocols, which would be applicable in clinical use. Methods and Material Livers of dipeptidylpeptidase IV (DPPIV)-deficient rats were preconditioned with partial liver external beam single dose IR at 25 Gy, 8 Gy, or 5 Gy, or fractionated IR at 5 × 5 Gy or 5 × 2 Gy. Four days after completion of IR, a partial …

Cancer ResearchTransplantation ConditioningDipeptidyl Peptidase 4medicine.medical_treatmentmedicineAnimalsHepatectomyRadiology Nuclear Medicine and imagingExternal beam radiotherapyPreparative RegimenRadiationbusiness.industryDose fractionationRatsRadiation therapyTransplantationmedicine.anatomical_structureLiverOncologyHepatocyteHepatocytesDose Fractionation RadiationTransplantation ConditioningHepatectomyNuclear medicinebusinessBiomarkersInternational Journal of Radiation Oncology*Biology*Physics
researchProduct

Lactate: A Metabolic Key Player in Cancer

2011

Abstract Increased glucose uptake and accumulation of lactate, even under normoxic conditions (i.e., aerobic glycolysis or the Warburg Effect), is a common feature of cancer cells. This phenomenon clearly indicates that lactate is not a surrogate of tumor hypoxia. Tumor lactate can predict for metastases and overall survival of patients, as shown by several studies of different entities. Metastasis of tumors is promoted by lactate-induced secretion of hyaluronan by tumor-associated fibroblasts that create a milieu favorable for migration. Lactate itself has been found to induce the migration of cells and cell clusters. Furthermore, radioresistance has been positively correlated with lactate…

Cancer ResearchTumor hypoxiaGlucose uptakeCellCancerBiologymedicine.diseaseRadiation ToleranceMetastasismedicine.anatomical_structureImmune systemOncologyCell MovementNeoplasmsImmunologymedicineCancer researchAnimalsHumansTumor EscapeGlycolysisLactic AcidWound healingGlycolysisCancer Research
researchProduct